#methadone

Overdose deaths rose by nearly 5% in 2019, and the pandemic could make matters worse.

This is one of many ways that people who use drugs can engage in harm reduction during the coronavirus pandemic.

A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.

Even after federal regulators relaxed rules requiring daily clinic visits, these bad actors are still bringing patients in for monitoring.

Experts are calling for greater flexibility in clinicians’ ability to deliver treatments for opioid use disorder.

A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.

Researchers examined increasing use of PrEP, expanding access to opioid use disorder treatment and improving engagement with HIV care.

Researchers found critical gaps in the scientific knowledge about the opioid epidemic.

A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.

Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.

Many of the 215 injection-drug-related HIV infections could have been averted from a swifter response, according to researchers’ estimates.

A group of experts has issued a call to arms, spotlighting missed opportunities for addiction treatment in hospital settings.

The Canadian province’s big push for needle exchange, opioid substitution therapy and HIV treatment access has been a success.

A team of researchers is studying how online video conferencing can put a virtual doctor into methadone clinics to deliver hep C treatment.

Methadone and buprenorphine-naloxone both lower injecting behaviors that put injection drug users at risk for HIV.

People with HIV who are on methadone maintenance therapy have an elevated risk of hearth rhythm abnormalities that can prove fatal.